Sort by: Date added | Date Published | Most Viewed

Headlines Tagged with Vaccines 1,152 headlines found


FDA Reviews Psychiatric Side Effects of Chantix

it will convene a public meeting in October to review the risks of psychiatric and behavioral side effects with Pfizer's anti-smoking drug Chantix. The agency said in a federal notice it will convene its panel of psychiatric drug experts to discuss the p
AP - Associated Press
added Apr 28, 2014 06:42

Russian scientists working on anti-smoking vaccine

Russian scientists are currently working on the first ever vaccine which could help quit smoking; it may be available in pharmacies in as early as five years. Dmitry Ovchinnikov, Deputy Director General of the company developing the drug, Selecta RUS conf
TASS (ru)
added Sep 12, 2013 12:16

[Canada] Vaughn Palmer: Leaked email about Liberals’ ‘political’ drug policy leaves a lingering smell

As to what it all means — who gave the orders, why the review was shut down, what was political about it — that was left hanging by the health minister. But at the very least, he and his colleagues have some explaining to do.
Vancouver (BC) Sun (ca)
added Jul 15, 2013 12:32

Cytos to Regain Rights to Smoking Cessation Vaccine

Cytos Biotechnology Ltd (SIX:CYTN) today announced that Novartis will discontinue the NIC002 project, which is a therapeutic vaccine candidate for the treatment of nicotine addiction.
PR Newswire
added Jan 23, 2013 14:30

Chantix May Up Heart Risk, FDA Warns

A meta-analysis ordered by the agency and conducted by drugmaker Pfizer found a higher occurrence of major adverse cardiovascular events -- including death, MI, and stroke -- with the drug than with placebo.
MedPage Today
added Dec 12, 2012 18:08

Now, innovative vaccine to help smokers kick the butt

Researchers at Weill Cornell Medical College have developed and successfully tested in mice an innovative vaccine that blocks addictive nicotine chemicals from reaching the brain.
ANI (in)
added Jun 28, 2012 13:16

Smoking Cessation: The Urgent Need for Increased Utilization of Varenicline

the existing totality of evidence suggests an urgent need to increase utilization of varenicline among the general population, as well as those with serious mental illness, to achieve smoking cessation among those attempting to quit. The relevant consider
American Journal of Medicine
added Mar 28, 2017 12:21

Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis

Varenicline appears to be significantly more effective than placebo in assisting with smoking cessation and reduction in people with severe mental illness. There appears to be no clear evidence that varenicline was associated with an increased risk of ne
Wiley Online Library
added Aug 15, 2016 13:14

No Clear Winner Seen Among Stop-Smoking Aids in Study

Results of the three approaches did not differ significantly at either six months or a year, the investigators found. At six months, the quit rate was 23 percent for the patch, 24 percent for Chantix, and 27 percent for the combination of patch and lozen
HealthDay [HealthScout]
added Jan 26, 2016 17:48

[Oregon] Chantix Case in Eugene calls attention to Mental Health Issues

On Nov. 17, 2014 in a courtroom in Eugene, Lamae Stout lost the lawsuit against PeaceHealth; Matthew McLaughlin, the dentist who prescribed Chantix, a drug that helps people quit tobacco; and Eugene Emergency Physicians. A jury found the defendants not g
Eugene (OR) Weekly
added Dec 4, 2014 19:36
Sign up for daily headlines All Headlines Featured Headlines U.S. Headlines International Headlines